United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2003_register
executive
2010-09-23
article
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Antibodies Against Type A Botulinum Neurotoxin
Notices
D09002ee1bdebd7ee
D09002ee1bdebd87b
United States
Department of Defense
originator
org
United States Government Agency or Subagency
United States
Department of the Army
originator
org
United States Government Agency or Subagency
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/465,276 entitled ``Antibodies Against Type A Botulinum Neurotoxin,'' filed December 16, 1999. The United States Government, as represented by the Secretary of the Army, has rights in this invention.
68 FR 41114
https://www.govinfo.gov/app/details/FR-2003-07-10/03-17519
03-17519
fr10jy03-35
3710-08-M
https://www.govinfo.gov/app/details/FR-2003-07-10/03-17519
https://www.govinfo.gov/content/pkg/FR-2003-07-10/html/03-17519.htm
https://www.govinfo.gov/content/pkg/FR-2003-07-10/pdf/03-17519.pdf
1 p.
41114
41114
68 FR 41114
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Antibodies Against Type A Botulinum Neurotoxin; Federal Register Vol. 68, Issue
NOTICE
03-17519
DEPARTMENT OF DEFENSE
Department of the Army
3710-08-M
03-17519
Notice.
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/465,276 entitled ``Antibodies Against Type A Botulinum Neurotoxin,'' filed December 16, 1999. The United States Government, as represented by the Secretary of the Army, has rights in this invention.
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.
Patent licenses; non-exclusive, exclusive, or partially exclusive:
Type A botulinum neurotoxin antibodies,
Federal Register
Vol. 68, no. 132
Office of the Federal Register, National Archives and Records Administration
2003-07-10
continuing
daily
deposited
born digital
179 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2003-07-10
P0b002ee1809b91ac
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr10jy03
https://www.govinfo.gov/app/details/FR-2003-07-10
https://www.govinfo.gov/content/pkg/FR-2003-07-10/pdf/FR-2003-07-10.pdf
https://www.govinfo.gov/content/pkg/FR-2003-07-10/xml/FR-2003-07-10.xml
fdlp
41051
41218
DGPO
2010-09-23
2023-05-04
FR-2003-07-10
machine generated
eng
FR
FR-2003-07-10
68
132